FSCN1 and endometrial carcinoma: In undifferentiated endometrial carcinomas, the studies reported a loss of E-cadherin and β-catenin and overexpression of FSCN1, galactin-3, cyclin D1, and p16, which is involved in EMT and invasion, thus contributing to aggressive behavior and poor prognosis [141,143,151].